Liposarcoma is a non-specific malignant tumor that consisted of differentiated or variedly abnormal adipose cells, which could occur in various parts of the body. In this paper, we reported reversible leukoencephalopathy syndrome occurred in a patient who underwent post-operative chemotherapy of hip liposarcoma and orally took apatinib that inhibits the tumor angiogenesis, which is as follows.
第一作者机构：[1]Hebei Univ, Affiliated Hosp, Baoding 071000, Hebei, Peoples R China
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Hu Ling,Tian Yuan,Zhang Xi,et al.A CASE OF REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME RESULTED FROM TREATMENT OF LIPOSARCOMA WITH APATINIB[J].ACTA MEDICA MEDITERRANEA.2020,36(3):1787-1789.doi:10.19193/0393-6384_2020_3_281.
APA：
Hu, Ling,Tian, Yuan,Zhang, Xi,Yu, Qian,Zhang, Xin...&Su, Lei.(2020).A CASE OF REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME RESULTED FROM TREATMENT OF LIPOSARCOMA WITH APATINIB.ACTA MEDICA MEDITERRANEA,36,(3)
MLA：
Hu, Ling,et al."A CASE OF REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME RESULTED FROM TREATMENT OF LIPOSARCOMA WITH APATINIB".ACTA MEDICA MEDITERRANEA 36..3(2020):1787-1789
